In a recent study published in Science, the VA Million Veteran Program (MVP) has identified 2068 genetic traits linked to various health conditions, offering new insights into the genetic architecture of complex diseases.
The VA MVP, one of the largest biobanks in the United States, studied over 635,000 participants from diverse backgrounds.
The program addresses a crucial gap in genetic research, which has predominantly focused on individuals of European ancestry.
With 29% of its participants sharing genetic similarities with African, Admixed American, and East Asian populations, the diversity in the study allows researchers to uncover genetic risk factors that may have been overlooked in less diverse studies.
The study utilized genome-wide association studies (GWAS) across 2,068 traits, employing advanced fine-mapping techniques to pinpoint specific genetic variants associated with these traits.
The findings revealed 26,049 variant-trait associations, with 3,477 being significant only when non-European populations were included [1].
Key findings
One of the notable discoveries includes a genetic variant associated with keloid scarring, a condition more prevalent in individuals of African ancestry.
This variant, found in the SLC22A18/SLC22A18AS genes, was identified only in the African genetic subgroup, illustrating how population-specific genetic variations can influence the prevalence and manifestation of certain conditions.
Similarly, the study found unique associations with traits such as alopecia areata and viral hepatitis B in Admixed American and East Asian populations, respectively [1].
Implications for the future
The MVP study’s findings have far-reaching implications for the future of precision medicine.
By identifying specific genetic variants associated with various health conditions, this research lays the groundwork for more targeted therapies and preventive measures.
For example, the study uncovered a rare variant in the PCAT2 locus associated with prostate cancer in African American men, which could lead to more personalized screening and treatment approaches [1].
Additionally, the study highlights the potential for addressing health disparities through genetics.
By identifying genetic risk factors specific to non-European populations, the research provides a valuable resource for developing interventions tailored to these groups, potentially improving health outcomes and reducing disparities [1].
Cautious optimism
Although the study identified numerous significant associations, the researchers acknowledge that these findings require validation in other populations and contexts.
Moreover, the complexity of gene-environment interactions means that genetic factors alone cannot fully explain health outcomes.
The study also emphasizes the need for continued efforts to increase diversity in genetic research.
As more biobanks and genomic studies expand their participant pools to include a wider range of genetic backgrounds, the ability to identify and understand the full spectrum of genetic influences on health will improve.
This will be crucial for developing truly personalized medical treatments and preventive measures.
[1] Science. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program
